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TheGolgi enzymeUDP-GlcNAc:lysosomal enzymeN-acetyl-
glucosamine-1-phosphotransferase (GlcNAc-1-phospho-
transferase), an222 hexamer, mediates the initial step in the
addition of the mannose 6-phosphate targeting signal on newly
synthesized lysosomal enzymes. This tag serves to direct
the lysosomal enzymes to lysosomes. A key property of
GlcNAc-1-phosphotransferase is its unique ability to distin-
guish the 60 or so lysosomal enzymes from the numerous non-
lysosomal glycoproteins with identical Asn-linked glycans. In
this study, we demonstrate that the two Notch repeat modules
and the DNA methyltransferase-associated protein interaction
domain of the subunit are key components of this recognition
process. Importantly, different combinations of these domains
are involved in binding to individual lysosomal enzymes. This
study also identifies the -binding site on the  subunit and
demonstrates that in the majority of instances the mannose
6-phosphate receptor homology domain of the  subunit is
required for optimal phosphorylation. These findings serve to
explain how GlcNAc-1-phosphotransferase recognizes a large
number of proteins that lack a common structural motif.
Correct targeting of newly synthesized acid hydrolases to
lysosomes is essential for this organelle tomaintain its function
of degrading intracellular and endocytosed material. In higher
eukaryotes, this process is mediated by the mannose 6-phos-
phate (Man-6-P)5 recognition system whereby the newly syn-
thesized acid hydrolases acquireMan-6-P residues in the Golgi
that serve as high affinity ligands for binding toMan-6-P recep-
tors (MPRs) in the trans-Golgi network and subsequent trans-
port to the endo-lysosomal system (1). The initial and most
critical step in the generation of theMan-6-P tag ismediated by
the Golgi enzyme UDP-GlcNAc:lysosomal enzyme N-acetyl-
glucosamine-1-phosphotransferase (GlcNAc-1-phospho-
transferase).This enzymebinds selectively to conformation-de-
pendent protein determinants in the 60 or so lysosomal acid
hydrolases and transfers GlcNAc-1-P from UDP-GlcNAc to
mannose residues on high mannose-type N-linked glycans of
the hydrolases (2). The GlcNAc is subsequently excised by a
second Golgi enzyme (“uncovering enzyme”) to generate the
high affinity Man-6-P ligand (3).
GlcNAc-1-phosphotransferase is an 222 hexamer that is
encoded by two genes (4–7). TheGNPTAB gene encodes the 
and  subunits, whereas the GNPTG gene encodes the  sub-
unit. Enzyme kinetic studies have indicated that the  and 
subunits specifically bind lysosomal acid hydrolases and medi-
ate the catalytic function of the enzyme (8, 9). The  subunit
enhances the rate of GlcNAc-P transfer to a subset of the acid
hydrolases without substantially altering the binding to these
acceptors. Consistent with this, analysis of the level of mannose
phosphorylation of the acid hydrolases in the brain of mice
lacking the  subunit, as estimated by the extent of binding to a
cation-independent (CI)-MPR affinity resin, indicated that
about one-third of the acid hydrolases were phosphorylated at
close to wild-type (WT) levels, whereas another third were
poorly phosphorylated with the final third showing intermedi-
ate levels of phosphorylation (9).
These studies leave unanswered the key question of how
GlcNAc-1-phosphotransferase specifically recognizes lyso-
somal acid hydrolases. In looking for clues, we examined the
domain structures of the , , and  subunits of this transferase
(10). The / subunits contain three identifiable domains as
follows: the Stealth domain, two Notch repeat modules, and a
DNA methyltransferase-associated protein (DMAP) interac-
tion domain. The Stealth domain resembles sequences within
bacterial genes that encode sugar-phosphate transferases
involved in cell wall polysaccharide synthesis and has been
shown to mediate the catalytic function of GlcNAc-1-phos-
photransferase (8, 10, 11). Importantly, the bacterial genes lack
the Notch repeats and the DMAP interaction domain, which
has been proposed to function as a protein-protein interaction
domain (12). Because the bacterial enzymes transfer sugar-
phosphates directly to polysaccharide acceptors without the
involvement of protein recognition, we hypothesized that the
mammalian transferase, in the course of protein evolution,
acquired the Notch and DMAP interaction domains to func-
tion in the specific recognition of protein determinants on
lysosomal acid hydrolases.
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Support for this hypothesis has come from studies of the
consequences ofmissensemutations inNotch 1 and theDMAP
interaction domain found in patients with the autosomal reces-
sive lysosomal storage disorders mucolipidosis II and III (10,
13). These mutations were shown to impair lysosomal enzyme
phosphorylation without altering the catalytic activity of the
transferase toward the simple sugar -methyl D-mannoside
(MM). This is consistent with a role for these domains in
binding to lysosomal enzymes.
The  subunit contains two recognizable domains as follows:
a Man-6-P receptor homology (MRH) domain (14, 15), and a
DMAP interaction domain (this study). TheMRHdomain con-
tains residues critical for mannose binding, but it lacks those
needed for phosphate binding (15). Although it has not been
shown to bind high mannose oligosaccharides, similar MRH
domains in other proteins do so (16, 17). The function of the
MRH and DMAP interaction domains of the  subunit in lyso-
somal acid hydrolase phosphorylation has not been examined
to date.
To gain a better understanding of the role of the domains of
the , , and  subunits of GlcNAc-1-phosphotransferase in
lysosomal enzyme recognition, we used the CRISPR/Cas9
genome-editing system to inactivate theGNPTAB andGNPTG
genes in HeLa cells and then determined the ability of various
mutants of these genes to restore phosphorylation of a panel of
lysosomal enzymes and proteins.
Our findings establish that the two Notch repeats along
with the DMAP interaction domain of the  subunit of
GlcNAc-1-phosphotransferase mediate the specific recogni-
tion of lysosomal acid hydrolases. Furthermore, we present evi-
dence that the requirement for the individual protein interact-
ing domains to achieve phosphorylation varies among the
acid hydrolase substrates. We also show that the  subunit
binds to the spacer region between Notch 2 and the DMAP
interaction domain, and we document a variable require-
ment for the MRH domain and the DMAP interaction
domain of the  subunit. Together, these findings provide
new insight into how lysosomal acid hydrolases are selec-
tively recognized by GlcNAc-1-phosphotransferase.
Experimental Procedures
Cell Lines—GNPTAB/ and GNPTG/ HeLa cells were
generated by CRISPR nuclease-induced targeted double strand
break at the Genome Engineering Center at Washington Uni-
versity School of Medicine (St. Louis, MO). HeLa cells were
obtained from ATCC (parental line). Exon 3 of GNPTAB was
targeted with guide RNA 5-GTAAACAACGTCAATCG-
GCA-3, whereas Exon 2 of GNPTG was targeted with guide
RNA 5-TTCGCTGCACCTGCCGGCGC-3 (Fig. 1). Se-
quencing determined that all three alleles of GNPTAB were
disruptedwith one allele having a 17-bp deletion, c.216_232del,
whereas the other two alleles had a 1-bp deletion c.221delC. In
the case of GNPTG, all three alleles had an insertion, c.61insT,
c.61insA, and c.61insG (see Fig. 1). All cell lines were main-
tained in DMEM (Mediatech, Inc.) containing 0.11 g/liter
sodium pyruvate and 4.5 g/liter glucose, supplemented with
10% (v/v) FBS (Atlanta Biologicals), 100,000 units/liter penicil-
lin, 100 mg/liter streptomycin (Life Technologies, Inc.), and 2
mM L-glutamine (Mediatech).
DNA Constructs—Human DMAP (amino acids 173–267)
cDNA was PCR-amplified from human GNPTG-FLAG cDNA
in pcDNA3.1() (10) and cloned into pGEX-6P-1 (GE Health-
care) using general molecular cloning techniques. Human
GNPTG-FLAG in pcDNA3.1() was modified by QuikChange
site-directedmutagenesis to generate the variousmutant con-
structs. The full cDNA sequences were confirmed by DNA
sequencing. Human GNPTAB-V5/His in pcDNA6 has been
described (10). The various / deletion constructs were made
by a two-step overlap-extension PCR process wherein the
native cDNA restriction fragment encoding the Notch
1-DMAP (amino acids 438–819) sequence was swappedwith a
similar PCR-generated restriction fragment encoding the spe-
cific deletion. The two Notch 1 repeat-containing construct
was generated by a three-step overlap-extension PCR process.
All of the sequences were confirmed to be correct by DNA
sequencing. In preliminary experiments, we found that deletion
of residues 431–819 gave rise to a mutant protein that was well
expressed and localized to theGolgi but hadno catalytic activity
toward MM, in agreement with De Pace et al. (18). By con-
trast, the 438–819 mutant had full catalytic activity (see
Fig. 3).
To generate the / and  bicistronic construct, a 1.5-kb
gBlocks gene fragmentwas synthesized (IDT Inc.) that encoded
the internal ribosomal entry site sequence from the pTandem
vector (EMD Millipore), followed by the human  cDNA
sequencewith the hemagglutinin (HA) tag nucleotide sequence
in-frame at the 3 end.
The NPC2 cDNA construct was generously provided by
Daniel Ory (Washington University School of Medicine, St.
Louis, MO). Sandra Hofmann (University of Texas Southwest-
FIGURE 1. Generation of GNPTAB/ and GNPTG/HeLa cell lines using
CRISPR/Cas9 genome editing. A and B, schematic of the base pairing
betweenaguideRNA (sgRNA_g11 forGNPTAB and sgRNA_g8 forGNPTG) and
the targeting loci of the two genes. The sequences of themutated alleles are
shown. All the insertions and deletions cause frameshift mutations and early
termination of translation.
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ern Medical Center, Dallas) kindly provided the cDNA con-
struct for PPT1.
Immunofluorescence Microscopy—To visualize lysosomes,
parental, GNPTAB/ and GNPTG/ HeLa cells were fixed
and stained as described (10), using mouse anti-human
LAMP-1 (H4A3-s) monoclonal antibody (Developmental
Studies Hybridoma Bank, Iowa City, IA).
To visualize the subcellular localization of the / and 
subunits, the various constructs were transfected into parental
or GNPTAB/ HeLa cells using Lipofectamine 3000 (Life
Technologies, Inc.) according to the manufacturer’s protocol.
Co-transfection of / and  subunit cDNAs was performed
using an 8:1 ratio, respectively. 24 h post-transfection, the cells
were fixed, and the / subunits were detected with affinity-
purified rabbit anti- antibody with the exception of the N1-
DMAP and the DMAP deletions, which were detected with
mouse anti-V5 monoclonal antibody (Life Technologies, Inc.).
The reason for this is that the rabbit anti- antibody is directed
against an epitope within the DMAP domain. This necessitated
the use of two different Golgi markers, GM130 and GOLPH4,
which were detected with mouse anti-GM130 monoclonal
antibody (BD Biosciences) and rabbit anti-GOLPH4 polyclonal
antibody (Abcam), respectively. The  subunit was detected
with either rabbit anti- antiserum that was kindly provided by
Thomas Braulke (UniversityMedical Center Hamburg-Eppen-
dorf, Hamburg, Germany) or with mouse anti-FLAG M2
monoclonal antibody (Sigma).
The processed cells were mounted in ProLong Gold anti-
fade mounting medium (Life Technologies, Inc.), and the
images were acquired with either a Zeiss LSM510 or an
LSM880 confocal microscope (Carl Zeiss Inc.). Images were
analyzed by ImageJ software (Fiji).
Binding of / to —To determine binding ofWT ormutant
/ to WT or mutant , HEK 293 cells were either transfected
with the co-expression bicistronic vector or co-transfected
with the individual / and  plasmids. Twenty four hours
post-transfection, cells were lysed in ice-cold buffer A (50 mM
NaH2PO4, 300mMNaCl, 0.5%Tween 20, 10mM imidazole, and
protease inhibitors) and clarified by centrifugation at 15,000
g. The supernatant was added to Ni-NTA beads (Life Technol-
ogies, Inc.) and tumbled for 2 h at 4 °C. Beadswerewashed three
timeswith ice-cold buffer B (bufferAwith 20mM imidazole and
no protease inhibitors), boiled in SDS sample buffer, and the
bound proteins resolved by SDS-PAGE, transferred to nitrocel-
lulose, and detected by Western blotting.
CI-MPR Affinity Chromatography and Enzyme Assays—Sol-
uble bovine CI-MPRwas purified fromFBS and covalently con-
jugated to cyanogen bromide-activated Sepharose 4B (Sigma)
at 1mg/ml as described (19). Two days post-transfection, HeLa
cells in a 6-well plate were collected and lysedwith 250l of cell
lysis buffer (25 mM Tris-Cl, pH 7.2, 150 mM NaCl, 1% Triton
X-100) containing protease inhibitors. 20 l of the CI-MPR-
Sepharose beads was washed twice with lysis buffer, and mixed
with 200 l of cell lysate. The mixture was incubated for 1 h at
4 °C with tumbling and then centrifuged at 2,400 g for 2 min
to pellet the beads, which were washed twice with lysis buffer
containing 5 mM glucose 6-phosphate. Finally, the beads were
resuspended in lysis buffer containing 10 mMMan-6-P to elute
the bound proteins. Lysosomal enzyme assays were performed
on the eluates as described previously (10). The enzyme activity
was normalized to the total protein concentration of the differ-
ent cell extracts.
GSTPulldownExperiments—Theprotocol for purification of
CathD from porcine spleen is detailed elsewhere (20, 21).
-GalA was a generous gift from Amicus Therapeutics (Cran-
bury, NJ), whereas -iduronidase was kindly provided by Wil-
liam Canfield (Genzyme, Boston, MA). GST and GST fusions
were expressed in and purified fromEscherichia coliBL21 (RIL)
cells (Agilent Technologies), and pulldown assays were
performed with the purified lysosomal enzymes exactly as
described (13).
Western Blotting—Proteins resolved by SDS-PAGE under
reducing or non-reducing conditions were transferred to nitro-
cellulose membrane and detected with antibodies as indicated
in the figure legends.
[2-3H]Mannose Labeling Experiments—Labeling experi-
ments were performed with parental, GNPTAB/, and
GNPTG/ HeLa cells as follows. 48 h post-transfection, cells
in 60-mm tissue culture plates were incubated with 50–150
Ci of [2-3H]mannose (PerkinElmer Life Sciences) for 2 h, fol-
lowed by the addition of complete medium containing 5 mM
glucose, 5 mM mannose, and 10 mM NH4Cl to stop mannose
uptake and induce secretion. The cells were incubated for an
additional 3 h before themediawere collected. In several exper-
iments, cell extracts were prepared and subjected to Western
blotting for  subunit content to confirm that the constructs
were being expressed at comparable levels.
Immunoprecipitation and Oligosaccharide Analysis—Acid
hydrolases secreted into the media were immunoprecipitated,
and oligosaccharides were isolated and analyzed essentially as
described in detail previously (22). For theCathD-myc,-Man-
myc, NPC2-myc, and -Man-HA experiments, 20 l of anti-
Myc monoclonal antibody (Santa Cruz Biotechnology) or 5 l
of anti-HAmonoclonal antibody (Sigma) was pre-bound to 100
l of protein G-agarose-PLUS beads (Santa Cruz Biotechnol-
ogy) prior to immunoprecipitation of labeled lysosomal hydro-
lases from the media. In the case of -Gal and PPT1, the
secreted enzymes were immunoprecipitated with protein
G-agarose-PLUS beads pre-bound to anti--Gal antibody
(Amicus Therapeutics) and rProtein A-agarose beads (Repli-
Gen) pre-bound to anti-PPT1 antibody (kindly provided by
Sandra Hofmann, University of Texas Southwestern Medical
Center, Dallas, TX), respectively. Immunoprecipitatedmaterial
was treatedwith endoglycosidaseH (NewEngland Biolabs) and
filtered with Ultracel-10K (EMD Millipore). The filtrate con-
taining neutral and phosphorylated high mannose glycans was
treated with mild acid to remove anyN-acetylglucosamine res-
idues still attached to the phosphate moieties and applied to a
QAE-column matrix to separate the oligosaccharides bearing
zero, one, or two Man-6-P residues. The retentate containing
Endo H-resistant complex oligosaccharides was treated with
Pronase (Roche Diagnostics) and fractionated on concanavalin
A-Sepharose 4B (GE Healthcare). The [2-3H]mannose content
of each fraction was determined, and the percent phosphoryla-
tion was calculated as described (22). In all cases, values
obtained in the mock transfection were subtracted.
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Results
GNPTAB/ and GNPTG/ HeLa Cells Are Differentially
Impaired in Lysosomal Enzyme Phosphorylation—To analyze
the function of the various domains of the subunits of
GlcNAc-1-phosphotransferase, we needed cell lines that lacked
either the/ or subunitswhilemaintaining good growth and
being readily transfectable. To achieve this goal, the CRISPR/
Cas9 genome-editing system was used to generate
GNPTAB/ and GNPTG/ HeLa cells. Confocal immuno-
fluorescence microscopy of these cells using the lysosomal/late
endosomal marker LAMP-1 revealed a striking enlargement of
lysosomes in both lines compared with the parental HeLa cells,
with the abnormality being greatest in the GNPTAB/ cells
(Fig. 2A). Both knock-out cell lines had a dramatic increase in
LAMP-1 content, as documented by Western blots for this
membrane protein (Fig. 2B). These findings are indicative of
major lysosomal dysfunction in the mutant cells. Despite this,
the cells grew well and were readily transfectable.
Whole cell extracts of theGNPTAB/ andGNPTG/ cells
had low but detectable levels of a panel of lysosomal acid hydro-
lases based on enzymatic assays. To determine whether
the residual hydrolases observed in the GNPTAB/ and
GNPTG/ cells contained any Man-6-P residues, we mea-
sured their binding to beads containing immobilized CI-MPR,
which exhibits high affinity binding to phosphorylated lyso-
somal proteins (23). Seven of the eight hydrolases assayed in the
GNPTAB/ lysates exhibited less than 1% of the binding
observed with the WT extract, whereas -mannosidase
(-Man) had 4% of WT binding (Fig. 2C). This indicates that
most of the residual activitiesmeasured in thewhole cell extract
from GNPTAB/ cells are in fact non-phosphorylated lyso-
somal enzymes that are in the process of traversing the secre-
FIGURE 2.GNPTAB/ andGNPTG/HeLa cells have enlarged lysosomes and are deficient in phosphorylated lysosomal proteins. A, confocal immu-
nofluorescence images of parental, /-deficient, and -deficient HeLa cells, stained for the late endosomal/lysosomal marker LAMP-1 (green). Scale bar, 10
m. B, immunoblot of cell lysates (20 g per lane) from parental, /-deficient, and -deficient HeLa cells probed for LAMP-1. C, lysates of the three cell lines
were incubated with CI-MPR affinity beads, and the binding of the various lysosomal proteins was determined by enzyme assays. Mean values obtained with
the parental HeLa cells are set to 100% S.D. (n 3–5).D, lysates of the three cell lineswere incubatedwith CI-MPR affinity beads, and the binding of the three
lysosomalproteinswasdeterminedbyWesternblots. E,WTandmutant cells transfectedwithplasmids encoding the four lysosomalproteinswere labeledwith
[2-3H]mannose, followed by immunoprecipitation of the proteins secreted into the media and determination of the percent N-glycans containing Man-6-P.
The percentage oligosaccharide phosphorylation S.D. for each enzyme in the three different cell lines is shown (n 2–5).
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tory pathway. Binding of these hydrolases in the GNPTG/
lysates to immobilized CI-MPR was also greatly reduced (Fig.
2C), but in three instances it was substantially increased over
that observed with the same enzymes from GNPTAB/ cells
as follows: arylsulfatase B, 16 0.4% versus 1.2 0.1%;-hexo-
saminidase (-Hex), 3.4 1.5% versus 0.3 0.2%; and -galac-
tosidase (-Gal), 1.3  0.5% versus 0.1  0.1%. In addition to
these acid hydrolases, the eluates of the CI-MPR affinity beads
were also analyzed for their content of cathepsin D (CathD),
Niemann-Pick disease, type C2 (NPC2), and palmitoyl-protein
thioesterase (PPT1) byWestern blotting (Fig. 2D). Whereas all
three proteins were found in the eluate of the WT cell lysate,
none were detected in the eluate of theGNPTAB/ cell lysate.
By contrast, two of these proteins (CathD and PPT1)were pres-
ent at substantial albeit reduced levels in the eluate of the
GNPTG/ cell lysate, whereasNPC2was recovered at close to
the WT level.
We next turned to the use of [2-3H]mannose labeling to
obtain quantitative determinations of the degree of Man-6-P
formation on the various lysosomal proteins. In these experi-
ments, cells were transfected with cDNA constructs encoding
the lysosomal proteins, and 48 h later, the cells were labeled for
2 hwith [2-3H]mannose and then chased for 3 h in the presence
of NH4Cl to stimulate lysosomal protein secretion. The protein
of interest was then immunoprecipitated from the media and
the percent of the N-linked high mannose glycans that con-
tained Man-6-P residues determined as described under
“Experimental Procedures.” This procedure avoids any loss of
Man-6-P thatmay occur if the phosphorylated proteins were to
reach the lysosome. As shown in Fig. 2E, in all instances the
lysosomal proteins expressed in the GNPTAB/ cells con-
tained less than 1% Man-6-P-containing glycans whereas the
same proteins expressed inWT cells were well phosphorylated
(36–47%Man-6-P-containing glycans). Similar to the findings
with the CI-MPR binding assays, -galactosidase A (-GalA)
was poorly phosphorylated in the GNPTG/ cells, whereas
CathD and PPT1were phosphorylated 26 4% and 33 2% as
well as occurred in WT cells, whereas NPC2 was phosphor-
ylated 86  6% of the WT level. These findings confirm
that the requirement for the  subunit of GlcNAc-1-phos-
photransferase to achieve optimal phosphorylation varies
greatly among the lysosomal proteins.
Deletion of the SubunitNotch 1-DMAP InteractionDomain
(Residues 438–819) Abolishes Acid Hydrolase Phosphor-
ylation—To test the hypothesis that the subunit Notch repeat
modules and theDMAP interaction domain function as protein
recognition elements, a construct with deletion of residues
438–819 (N1-DMAP) of the / precursor was prepared.
This construct lacked bothNotch repeats and theDMAP inter-
action domain along with the intervening spacer regions (Fig.
3A). TheN1-DMAP construct waswell expressed and, in fact,
gave rise to substantially more mature / than the construct
encoding theWT/ precursor (Fig. 3B). As the cleavage of the
/ precursor is mediated by the site 1 protease in the Golgi
(24), the finding of increased levels of the  subunit indicates
that themutant protein is efficiently delivered to theGolgi. This
was confirmed by showing that the deletion mutant co-local-
ized with the Golgi marker, GOLPH4, using confocal immuno-
fluorescence microscopy (Fig. 3C). Furthermore, the mutant
protein exhibited strong activity toward the simple sugar
MM, consistent with an increased level of cleaved  subunit
(Fig. 3D). This establishes that the catalytic function of this
mutant was intact. Importantly, the lysosomal acid hydrolases
of GNPTAB/ cells transfected with the deletion mutant
failed to acquire any detectable Man-6-P, in contrast to trans-
fection with the construct encoding WT / precursor (Fig.
3E). Thus, in the absence of the Notch repeats and the DMAP
interaction domain, this catalytically active, Golgi-localized
GlcNAc-1-phosphotransferase lost its ability to phosphorylate
lysosomal acid hydrolases. This finding establishes that these
domains are required for the selective recognition of acid
hydrolase substrates.
 Subunit Binds to the Spacer Region (Residues 535–694) of
the  Subunit—Because the function of the N1-DMAP con-
structwould be impaired if the binding of the subunitwas lost,
it became necessary to identify the binding site on the / pre-
cursor for the  subunit and determine whether or not the
N1-DMAP construct harbors this site. In the initial experi-
ment, the WT / precursor and the N1-DMAP construct
were co-expressed with the  subunit in GNPTAB/ cells,
followed by confocal immunofluorescence microscopy to
determine the subcellular distribution of the various subunits.
Cells transfected with the  subunit alone served as a control.
As shown in Fig. 3F, the subunit co-localizedwith theWT/
subunits in the Golgi but was undetectable in the Golgi of cells
transfected with the N1-DMAP construct or with  alone.
These findings indicate that the  subunit localizes to the Golgi
via binding to the / subunits and that this interaction is lost
in the N1-DMAP construct, implicating this region of the 
subunit as the -binding site.
To localize the  subunit-binding sitemore precisely, a series
of constructs with deletion of either Notch 1, Notch 2, the
spacer region (S2) between Notch 2 and the DMAP interaction
domain, and the DMAP interaction domain itself were pre-
pared (Fig. 4A). These constructs were expressed in HeLa cells
where they localized to the Golgi and exhibited good catalytic
activity toward MM (Fig. 4, B–D). The various constructs
were then tested for their ability to bind the  subunit. For these
assays, HEK 293 cells were either transfected with a bicistronic
vector that encoded the various / constructs containing a
C-terminal V5-His tag along with the  subunit with a C-ter-
minal HA tag (Fig. 5A) or co-transfected with individual
plasmids encoding / or  (Fig. 5B). Twenty four hours post-
transfection, the cells were lysed and the / subunits affinity-
purified on Ni-NTA beads. The bound subunits were eluted,
subjected to SDS-PAGE, and analyzed for the content of  and
 subunits byWestern blotting. As shown in Fig. 5,A and B, the
 subunit co-purified with the WT, N1, N2, and DMAP
/ constructs but was not detectable in theS2,N1-DMAP,
and N2-DMAP mutants. This establishes that the  subunit
binds to the 535–694-amino acid spacer region of the  sub-
unit. Because the N1, N2, and DMAP interaction domain
constructs retain  subunit binding, any impairment of these
mutant proteins in lysosomal enzyme phosphorylation cannot
be attributed to the lack of the  subunit.
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Effect of the / Deletion Mutants on Restoration of Lyso-
somal EnzymePhosphorylation—The ability of the/ deletion
mutants to restore phosphorylation of five endogenous acid
glycosidases in GNPTAB/ cells, as determined by the CI-
MPR affinity binding assay, is shown in Fig. 6A with the values
plotted as percent of rescue obtained with the WT construct.
Deletion of Notch 2 strongly inhibited phosphorylation of all
the glycosidases, whereas deletion of Notch 1 was less detri-
mental, with levels of phosphorylation ranging from 100% of
WT (- and -Man) down to 60% ofWT (-Hex). The effect of
deleting the DMAP interaction domain was also variable,
ranging from a 10% decrease in phosphorylation relative to
WT (-Hex) to a 64% decrease in -Man phosphorylation.
Deletion of the S2 domain, which results in the loss of bind-
ing of the  subunit, strongly inhibited phosphorylation of all
the glycosidases. This was expected as these five enzymes are
dependent on the  subunit for phosphorylation (Fig. 2C).
Importantly, increasing the level of expression of the various
constructs did not alter the extent of correction of phosphor-
ylation. In all instances the level of expression was at least
6-fold greater than the endogenous activity in parental HeLa
cells.
We next investigated the ability of the various / deletion
mutants to phosphorylate a panel of lysosomal proteins using
the [2-3H]mannose-labeling procedure to quantitate the degree
of phosphorylation. As shown in Fig. 6B, the consequences of
deletingNotch 1, Notch 2, or theDMAP interaction domain on
the generation of the Man-6-P residues on -GalA and - and
-Man as measured by this technique are mostly in agreement
with the results obtained with the CI-MPR affinity resin bind-
ing assay. Thus, deletion of Notch 2 strongly inhibited phos-
phorylation of the three acid glycosidases, whereas loss of
Notch 1 substantially lowered phosphorylation of -GalA,
while having a smaller inhibitory effect on the other two glyco-
FIGURE 3. The N1-DMAP mutant has catalytic activity but is unable to phosphorylate lysosomal enzymes. A, schematic of GlcNAc-1-
phosphotransferase / subunit modular arrangement and deletion of the Notch 1 through DMAP interaction domain (residues 438–819). B, immunoblot
analysis ofWT/ versus theN1-DMAPdeletionmutant expressed inGNPTAB/HeLa cells probedwith anti-V5 antibody.C, confocal immunofluorescence
images of parental HeLa cells transfected with WT / or the N1-DMAP mutant and co-localized with the Golgi markers GM130 or GOLPH4, respec-
tively (see “Experimental Procedures”).D, phosphotransferase activity toward the simple sugarMM, using extracts ofGNPTAB/ cells transfectedwith
vector, WT /, or N1-DMAPmutant plasmids. E, transfection of GNPTAB/ HeLa cells with WT / but not the N1-DMAPmutant restores lysosomal
enzyme phosphorylation as determined by binding to CI-MPR affinity beads. Mean values obtained with cells transfected with WT / are set to
100%  S.D. F, confocal immunofluorescence images of GNPTAB/ cells co-expressing  with WT / (top) or with the N1-DMAP mutant (bottom).
Scale bars, 10 m.
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sidases. The only significant discrepancy was observed with
-Man where deletion of the DMAP interaction domain had a
lesser effect on phosphorylation asmeasured by this assay. Also
shown are the results with CathD, PPT1, and NPC2. The find-
ingswithNPC2 are of particular interest because the phosphor-
ylation of this protein ismostly independent of the  subunit. In
this case, deletion ofNotch 1wasmore harmful than deletion of
Notch 2 (58% versus 38% decrease in phosphorylation, respec-
tively), whereas deletion of the DMAP interaction domain had
no impact on phosphorylation. The finding that the N1-
DMAP mutant phosphorylated NPC2 very poorly indicates
that the two Notch modules are the critical domains in the
phosphorylation of NPC2. The results were similar with PPT1
except in this case loss of Notch 2 was more detrimental than
loss of Notch 1 (56% versus 30% decrease in phosphorylation,
respectively). The phosphorylation of CathD, however, was
completely lost in the absence of Notch 2 and 60% inhibited
when Notch 1 was deleted.
Taken together, these findings show that the Notch 1 and
2 repeat modules and the DMAP interaction domain of the 
subunit all contribute to the generation of Man-6-P-residues
in lysosomal enzymes. However, their relative impact varies
with each lysosomal enzyme. In addition, the  subunit is
critical for phosphorylation of a subset of the lysosomal
proteins.
Notch 1 Repeat Module Cannot Substitute for the Notch 2
Repeat Module—One explanation for why deletion of the
Notch 2module impairs phosphorylation ofmost of the hydro-
lases more than deletion of Notch 1 is that it mediates a func-
tion that cannot be carried out byNotch 1. Alternatively, it may
be located in a more critical site of the transferase. To address
this issue, a construct was prepared in which the Notch 2 mod-
ule was replaced by the Notch 1 module (Fig. 7A). This
approach preserved the overall spacing of the domains of the
transferase. This construct was well expressed, localized to
the Golgi, bound , and exhibited good catalytic activity
toward MM (Fig. 7, B–E). However, it functioned only
slightly better than the N2 construct in restoring the phos-
phorylation of endogenous acid glycosidases in the
GNPTAB/ cells (Fig. 7F). This finding clearly shows that
Notch 1 is unable to functionally substitute for Notch 2 in
GlcNAc-1-phosphotransferase.
FIGURE 4. Expression of deletionmutants of /. A, schematic of the various / deletion constructs expressed in HEK 293 cells. B,Western blot of WT /
and mutants expressed in GNPTAB/ HeLa cells. 20 g of each cell extract was loaded, and the / precursor and  subunits were detected with an anti-V5
antibody.C, catalytic activity ofWT/ and themutants towardMMusingequal amountsofwhole cell extracts. Thevector-only transfectedGNPTAB/HeLa
cell extract served as a control. D, confocal immunofluorescence microscopy of HeLa cells transfected with plasmids encoding the various / deletion
mutants. Cells were fixed 24 h post-transfection and probed with anti- antibody (N1, N2, and S2), or with the anti-V5 antibody (DMAP). The Golgi
markers, GM130 and GOLPH4, were detected with anti-GM130 and anti-GOLPH4 antibodies, respectively. Scale bar, 10 m.
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Rescue of Acid Hydrolase Phosphorylation in GNPTG/
Cells by WT and Mutant  Subunits—The  subunit contains
the following two recognizable domains that are candidates for
participating in lysosomal enzyme binding and phosphoryla-
tion: the MRH domain and the DMAP interaction domain.
Although previously not recognized as such, blast analysis
revealed that the DMAP interaction domain shares similari-
ties with the DMAP interaction domain of the  subunit (Fig.
8A) and shows significant conservation in the N-terminal half
among various species (Fig. 8B). Similar to the previously
reported findings with a GST fusion protein containing the
DMAP interaction domain of the  subunit (13), a GST fusion
protein containing the DMAP interaction domain of the  sub-
unit pulled down several lysosomal hydrolases, but not the non-
lysosomal protein tissue factor pathway inhibitor (Fig. 8C). The
affinity of the GST-DMAP was similar to that of GST-
DMAP based on the pattern of release of the bound glycosi-
dases in the washing steps (Fig. 8D). In both cases, the amount
of glycosidase activity released in the washes was much greater
than that of the control GST. This supports the notion that the
 subunit may contribute to the binding of lysosomal acid
hydrolases. Unfortunately, despite numerous attempts using
alanine scanning and deletion mutagenesis, we were unable to
generate a  subunit with a mutant DMAP interaction domain
that had lost the ability to bind to acid hydrolases but retained
proper folding in the endoplasmic reticulum and localization in
the Golgi. This prevented us from directly analyzing the role of
the DMAP interaction domain in the overall function of the 
subunit.
The MRH domain was inactivated by making an R134K/
E153Q double mutation (Fig. 9A), as equivalent mutations in
the MRH domain of the CI-MPR had been shown to abolish
mannose binding without altering folding (15, 25). Preliminary
experiments showed that the  mutant was well expressed,
interacted with the / subunits in the Ni-NTA pulldown
assay, and localized to the Golgi in a process that required co-
expression of/ (Fig. 9,B andC). This indicates that theMRH
mutations do not impair association with the / precursor,
exit from the endoplasmic reticulum, or localization in the
Golgi.
The effect of the MRHmutations on the ability of the  sub-
unit to restore endogenous acid glycosidase phosphorylation in
GNPTG/ cells as determined by CI-MPR affinity resin bind-
ing is shown in Fig. 9D. These enzymes are highly dependent on
the  subunit for phosphorylation (Fig. 2C). In all cases, trans-
fection of theWT  subunit cDNA substantially restored phos-
phorylation.By contrast, theMRHmutant exhibitedpoorphos-
phorylation of these acid glycosidases, especially- and-Man,
-L-fucosidase (-Fuc), and -L-iduronidase (-Idu) (93–98%
inhibition), while having somewhat better activity toward
-Hex,-Gal, and-GalA (65–73% inhibition). A similar result
was obtained with -GalA when the level of Man-6-P synthesis
was determined by the [2-3H]mannose labeling procedure
(Fig. 9E).
It is also apparent from Fig. 9E that the  subunit enhance-
ment of phosphorylation of CathD and PPT1 over the vector
only control is largely dependent on an intact MRH domain.
In the case of NPC2, the presence of the  subunit had only a
very small stimulatory effect on phosphorylation, but this
effect also appeared to be MRH-dependent. Together, these
findings demonstrate that the MRH domain of the  subunit
participates in the phosphorylation of acid hydrolases,
although its role varies depending on the particular hydro-
lase in question.
Discussion
Although the components of the Man-6-P targeting system
have been known for many years, the critical issue of how
GlcNAc-1-phosphotransferase selectively recognizes lyso-
somal acid hydrolases has remained a mystery. Enzyme kinetic
studies using recombinant // and / GlcNAc-1-
phosphotransferase have indicated that the / subunits medi-
ate the binding to the conformation-dependent protein domain
on the lysosomal enzymes as well as the catalytic function,
whereas the  subunit enhances the rate of GlcNAc-P transfer
to a subset of the acceptors (9). Although informative, these
studies did not address the role of the various domains of the
transferase in these functions. Some insight into this question
has come from the analysis of missense mutations in the
GNPTAB gene present in patients with mucolipidosis II and III
FIGURE 5.The subunit binds to aminoacids 535–694of the subunit.A
and B, lysates of HEK 293 cells expressing WT / or the deletion mutants
along with WT were incubated with Ni-NTA affinity beads to pull down the
various forms of the / subunits.  only served as a control. The bound
material was assayed for the content of/ and  subunits by SDS-PAGE and
Western blotting using anti-V5 antibody to detect / and anti-HA antibody
(A) or anti-FLAG antibody (B) to detect . I, 3% of input; P, 25% of pellet frac-
tion. *, line denotes position where the nitrocellulose membrane was cut to
allow for probing of the / and  subunits with different antibodies. Even
long exposures of the blot failed to show detectable binding of  to the
N1-DMAP, N2-DMAP, and S2 mutants of / (data not shown).
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(10, 13). These studies implicated the Notch 1 repeat module
and the DMAP interaction domain of the  subunit in lyso-
somal acid hydrolase recognition. However, the limited num-
ber of patientmutations prevented analysis of some domains of
the / subunits as well as the  subunit.
Two key advances in this study allowed us to overcome the
limitations of the previous studies. The first was the use of
CRISPR/Cas9 genome editing to generate readily transfectable
HeLa cells in which theGNPTAB or theGNPTG gene had been
inactivated. The second was the finding that single or multiple
domains located in the middle of the GNPTAB gene could be
deleted without impairing the catalytic function or Golgi local-
ization of the gene product. In fact, deletion of Notch 1 through
DMAP (residues 438–819) of the  subunit gives rise to an /
precursor that exited the endoplasmic reticulum more effi-
ciently than the WT species, localized properly to the Golgi,
and retained full catalytic activity toward the simple sugar
MM. This allowed for the interrogation of the function of
these domains within this region.
The critical finding is that the Notch 1-DMAP deletion
mutant failed to phosphorylate lysosomal enzymes demon-
strating the essential role for this region of the  subunit in
GlcNAc-1-phosphotransferase function.Within this region we
found that the Notch 1 and 2 repeat modules along with the
DMAP interaction domain participate to varying degrees in
the phosphorylation of individual lysosomal proteins. Thus, in
the case of the glycosidases -Hex, -GalA, -Gal, and - and
-Man, the loss of Notch 2 inhibited phosphorylation much
more than the loss ofNotch 1 or theDMAP interaction domain.
However, deletion of theDMAP interaction domain resulted in
substantial inhibition of-Manphosphorylation,whereas dele-
tion of Notch 1 had no effect. The opposite was true in the case
of -Hex. The situation was different with NPC2 and PPT1
where loss of Notch 1 or Notch 2 resulted in similar impair-
FIGURE 6. Effect of the/ domain deletions on lysosomal enzyme phosphorylation. A, lysates of GNPTAB/HeLa cells transfected withWT or deletion
mutants of /were incubated with CI-MPR affinity beads, and the boundmaterial was assayed for the content of the various acid glycosidases. Mean values
obtained with cells transfected with the various mutants are compared with WT /, which is set to 100% (n 3–5). B, GNPTAB/ cells were co-transfected
with the various forms of / along with the indicated lysosomal protein encoding plasmids. Following [2-3H]mannose labeling, the degree of N-glycan
phosphorylation of the lysosomal proteins was determined. Values obtained with the various mutants are compared with WT /, which is set to 100% (n
2–3).
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ments of phosphorylation, whereas loss of the DMAP interac-
tion domain had no effect on phosphorylation. Taken together,
these data reveal a variable requirement for the Notch repeat
modules and the DMAP interaction domain among this set of
lysosomal proteins, although in most instances the Notch 2
module was dominant.
The inability of Notch 1 to restore acid hydrolase phosphor-
ylation when inserted into the Notch 2 location points to a
special role for Notch 2 inGlcNAc-1-phosphotransferase func-
tion. In this regard, it is notable that although the two Notch
repeat modules have an identical number of residues and the
same spacing of the three disulfide bonds, they only share 50%
identity in amino acid sequence. Furthermore, the sequences of
Notch 1 and Notch 2 are highly conserved among species, con-
sistent with each module having a distinct role in the function
of the transferase. At this point, the role of the Notch repeat
modules in the selective phosphorylation of lysosomal acid
hydrolases is unclear. One possibility that we are currently pur-
suing is that they directly engage the conformation-dependent
binding site of the acid hydrolases. This would be consistent
with the role of the Notch repeat modules in other proteins. In
the Notch receptors, the three tandemly repeated Notch mod-
ules function to prevent proteolytic cleavage of the receptor
until binding of a physiologic ligand occurs (26). This autoinhi-
bition is achieved by theNotch repeatmodules forming numer-
ous interdomain contacts that allow these modules to wrap
around the juxtamembrane heterodimerization domain of the
receptor and mask the protease cleavage site. Aside from the
Notch receptors, the only other proteins reported to contain
Notch repeat modules are the metalloproteinase pregnancy-
associated plasma protein-A (PAPP-A) and its homologue
PAPP-A2 (27, 28). These proteases act on a limited number of
substrates, with PAPP-A cleaving only IGF-binding proteins 4
and 5, whereas PAPP-A2 only cleaves IGFBP-5. Importantly,
the threeNotch repeatmodules of PAPP-A have been shown to
mediate the proteolytic specificity of this enzyme toward
IGFBP-4 (27). If the twoNotch repeatmodules of the-subunit
of GlcNAc-1-phosphotransferase prove to directly interact
with multiple lysosomal acid hydrolases, it will expand the role
of these domains.
FIGURE 7. Effect of substituting the Notch 2 repeat module with Notch 1. A, schematic showing / construct with two Notch 1modules. B,Western blot
of GNPTAB/ cells transfected with either WT /, the 2Notch1 mutant, or the N2 mutant. 20 g of each cell lysate was loaded. C, confocal immunofluo-
rescence images of GNPTAB/ cells expressing the 2Notch1mutant. Cells were fixed 24 h post-transfection and probedwith anti- antibody (2 Notch 1) and
anti-GM130 antibody for theGolgimarker GM130. Scale bar, 10m.D, lysates of HEK 293 cells expressingWT/or the 2Notch1mutant alongwithWTwere
incubated with Ni-NTA affinity beads to pull down the various forms of the / subunits.  only served as a control. The bound material was assayed for the
contentof/and subunitsbySDS-PAGEandWesternblottingusinganti-V5antibody todetect/andanti-FLAGantibody todetect. I,3%of input;P,25%
of pellet fraction. E, phosphotransferase activity toward the simple sugar MM, using extracts of GNPTAB/ cells transfected with either vector, WT /, the
2Notch1mutant, or theN2mutant. n 3. F, GNPTAB/HeLa cells transfectedwith eitherWT/, the 2Notch1mutant, or theN2mutantwere assayed for
activity of the indicated enzymes as determined by binding to CI-MPR affinity beads. Mean values obtainedwith the twomutants are comparedwithWT /,
which is set to 100% S.D. (n 3). *, line denotes position where the nitrocellulose membrane was cut to allow for probing of the / and  subunits with
different antibodies.
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With regard to the role of the DMAP interaction domain, it
should be noted that we previously reported that the K732N
and L785W missense mutations in this domain were defective
in phosphorylating purified porcine CathD in vitro, and the
K732N mutant was impaired in correcting the phenotypic
abnormalities observed in a zebrafish model of ML II (13).
Therefore, itwas surprising that theDMAPmutantphosphor-
ylated CathD quite well in the current transfection studies
while exhibiting defective phosphorylation of several other
lysosomal hydrolases. The reason for this discrepancy is not
clear at this time.
Another key observation is that the binding site for the 
subunit resides in the spacer region (amino acids 535–694)
located between the Notch 2 and DMAP interaction domains.
As the  subunit facilitates phosphorylation of most of the
lysosomal hydrolases, it appears that all of the elements
involved in the selective phosphorylation of lysosomal proteins
are localized to one region of the transferase. It should be noted
that while this manuscript was in preparation, De Pace et al.
(18), using a different approach, reported that the  subunit
binds to the same spacer region of the  subunit. These data do
not exclude additional roles for the spacer region between
amino acids 535–694.
Consistent with our previous findings withGNPTG/mice
(9), we observed a variable impact on the phosphorylation of
the lysosomal proteins of GNPTG/ HeLa cells. This ranged
from a modest 15% decrease in phosphorylation of NPC2 to
almost a complete loss of phosphorylation of a number of the
acid glycosidases. To gain insight into how the  subunit func-
tions in the phosphorylation process, we analyzed the role of
the MRH domain of this subunit. Although the presence of the
MRH domain of the  subunit was initially recognized in 2001
(14), this is the first study to directly address its role in lyso-
somal protein phosphorylation. Our findings clearly show that
mutatingMRH residues required for mannose binding inhibits
the ability of  to facilitate the phosphorylation of those lyso-
somal acid hydrolases that are dependent on this subunit.
These results indicate that binding of the MRH domain to the
highmannose oligosaccharides of the acid hydrolases is central
to the function of the  subunit.
How might this be important? A clue comes from the analy-
sis of the phosphorylation of various acid hydrolases. A number
of studies have found that among acid hydrolases withmultiple
N-linked glycans, only a subset of the glycans are phosphorylat-
ed (29–33). This can be explained if some of the glycans have
unfavorable locations on the surface of the hydrolase relative
to the site of the protein recognition domains where
GlcNAc-1-phosphotransferase docks. Presumably only glycans
within a certain range of the docking site will be able to engage
the catalytic elements of the transferase (34, 35). We have pre-
viously speculated that binding of the MRH domain to
selected high mannose glycans with unfavorable locations may
FIGURE 8. TheDMAP interaction domain binds lysosomal enzymes. A, human/ and DMAP interaction domains are alignedwith identical amino acid
residues shown in red. B, alignment of the DMAP interaction domains of  from several species shows a high degree of conservation in the N-terminal half of
thedomain. Becauseof the variationof 5 aminoacid residues, only bovine showsupas aDMAP interactiondomain in anNCBI Blast search.C,pulldownassays
were performed with GST fusions to / and DMAP interaction domains using the purified lysosomal enzymes indicated, along with tissue factor pathway
inhibitor (TFPI), a non-lysosomal secreted glycoprotein. 0.2% of the input and 20% of the pellet fraction was loaded. D, release of bound enzyme activity was
measured following wash steps 1 and 2 to determine loss of bound material as a result of the wash steps (n 2).
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reposition the glycans sufficiently to allow successful phosphor-
ylation (9). The findings presented here are fully consistentwith
this proposal. The binding of the DMAP interaction domain
to the protein portion of the acceptor could aid in this process.
Taken together, these findings provide strong support for the
hypothesis that mammalian GlcNAc-1-phosphotransferase
evolved from an ancestral sugar-P-transferase gene that
acquired the Notch repeat modules and the DMAP interaction
domains along with a binding site for the  subunit to meet the
requirement to selectively recognize the 60 or so lysosomal pro-
teins. These lysosomal proteins catalyze many different reac-
tions and have a great variety of structures to perform these
functions. Taking this into account, it is understandable that
these 60 different proteins do not appear to share an identical
conformation-dependent protein docking site for GlcNAc-1-
phosphotransferase nor an N-linked glycan located a standard
distance from the docking site. This speaks to the necessity
to have flexibility in the function of GlcNAc-1-phos-
photransferase. The involvement of two Notch repeat modules
and the DMAP interaction domain of the  subunit along with
a second DMAP interaction domain and the MRH domain of
the  subunit would serve to provide the flexibility needed for
binding the various lysosomal proteins and positioning their
N-linked glycans so that they are accessible to the catalytic ele-
ments of the transferase.
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